Journal Article

Heterozygous NPR2 Variants in Idiopathic Short Stature

Jenko Bizjan, Barbara, Debeljak, Maruša, Stavber, Lana, Omladič, Jasna Šuput, Battelino, Tadej, Kotnik, Primož, Kovač, Jernej, Gaia, Maria Joao, Dovč, Klemen, Hovnik, Tinka

2022

Overview

Heterozygous variants in the NPR2 gene, which encodes the B-type natriuretic peptide receptor (NPR-B), a regulator of skeletal growth, were reported in 2–6% cases of idiopathic short stature (ISS). Using next-generation sequencing (NGS), we aimed to assess the frequency of NPR2 variants in our study cohort consisting of 150 children and adolescents with ISS, describe the NPR2 phenotypic spectrum with a growth pattern including birth data, and study the response to growth hormone (GH) treatment. A total of ten heterozygous pathogenic/likely pathogenic NPR2 variants and two heterozygous NPR2 variants of uncertain significance were detected in twelve participants (frequency of causal variants: 10/150, 6.7%). During follow-up, the NPR2 individuals presented with a growth pattern varying from low–normal to significant short stature. A clinically relevant increase in BMI (a mean gain in the BMI SDS of +1.41), a characteristic previously not reported in NPR2 individuals, was observed. In total, 8.8% participants born small for their gestational age (SGA) carried the NPR2 causal variant. The response to GH treatment was variable (SDS height gain ranging from −0.01 to +0.74). According to the results, NPR2 variants present a frequent cause of ISS and familial short stature. Phenotyping variability in growth patterns and variable responses to GH treatment should be considered.

• Publisher: MDPI AG,MDPI
• Subject: Age / Birth weight / Brain natriuretic peptide / Families & family life / genes / Genomes / Gestational age / Growth hormones / Growth patterns / growth retardation / heterozygosity / Laboratories / natriuretic peptide receptors / Next-generation sequencing / phenotype / Phenotyping / Segregation / somatotropin